Matches in SemOpenAlex for { <https://semopenalex.org/work/W4249558239> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4249558239 endingPage "1413" @default.
- W4249558239 startingPage "1406" @default.
- W4249558239 abstract "BACKGROUND It remains controversial whether chemotherapy and/or radiotherapy are/is contraindicated for esophageal carcinoma patients with malignant fistulae. In some case reports, closure of fistulae by chemotherapy or radiotherapy has been reported. The current study investigated chemoradiotherapy for these patients using various primary treatments to manage the pulmonary complications. The aim of this study was to evaluate the efficacy and feasibility of chemoradiotherapy for patients with locally advanced esophageal carcinoma with malignant fistulae. METHODS Patients with endoscopically or radiologically confirmed fistulae were treated with concomitant chemoradiotherapy. Closure of fistulae was assessed by esophagography or endoscopy. Oral food intake also was assessed before and after treatment. RESULTS Of 202 esophageal carcinoma patients treated at National Cancer Center Hospital East between July 1992 and May 1998, 24 patients (11.9%) developed malignant fistulae. Twelve patients developed fistulae before treatment and the remaining patients developed fistulae during treatment. Closure of the fistulae after chemoradiotherapy was observed in 17 of these patients (70.8%), and 16 of these 17 patients (94.1%) had oral alimentation restored after successful treatment. The median survival time from the diagnosis of the fistula for all patients with fistulae was 198 days; in the patients whose fistulae were present before chemoradiotherapy, the median survival time was 238 days. CONCLUSIONS These results suggest that the presence of malignant fistulae does not contraindicate chemoradiotherapy. Once the inflammation due to the fistula has been controlled, chemoradiotherapy should be utilized because it may provide the best chance for survival and palliation of severe dysphagia. Cancer 1999;86:1406–13. © 1999 American Cancer Society." @default.
- W4249558239 created "2022-05-12" @default.
- W4249558239 creator A5002423375 @default.
- W4249558239 creator A5010090426 @default.
- W4249558239 creator A5022854492 @default.
- W4249558239 creator A5024904484 @default.
- W4249558239 creator A5047518459 @default.
- W4249558239 creator A5051763064 @default.
- W4249558239 creator A5071442298 @default.
- W4249558239 creator A5073330859 @default.
- W4249558239 creator A5082598030 @default.
- W4249558239 creator A5091871631 @default.
- W4249558239 date "1999-10-15" @default.
- W4249558239 modified "2023-10-08" @default.
- W4249558239 title "Concurrent chemoradiotherapy for esophageal carcinoma patients with malignant fistulae" @default.
- W4249558239 doi "https://doi.org/10.1002/(sici)1097-0142(19991015)86:8<1406::aid-cncr4>3.3.co;2-v" @default.
- W4249558239 hasPublicationYear "1999" @default.
- W4249558239 type Work @default.
- W4249558239 citedByCount "1" @default.
- W4249558239 crossrefType "journal-article" @default.
- W4249558239 hasAuthorship W4249558239A5002423375 @default.
- W4249558239 hasAuthorship W4249558239A5010090426 @default.
- W4249558239 hasAuthorship W4249558239A5022854492 @default.
- W4249558239 hasAuthorship W4249558239A5024904484 @default.
- W4249558239 hasAuthorship W4249558239A5047518459 @default.
- W4249558239 hasAuthorship W4249558239A5051763064 @default.
- W4249558239 hasAuthorship W4249558239A5071442298 @default.
- W4249558239 hasAuthorship W4249558239A5073330859 @default.
- W4249558239 hasAuthorship W4249558239A5082598030 @default.
- W4249558239 hasAuthorship W4249558239A5091871631 @default.
- W4249558239 hasBestOaLocation W42495582391 @default.
- W4249558239 hasConcept C121608353 @default.
- W4249558239 hasConcept C126322002 @default.
- W4249558239 hasConcept C126838900 @default.
- W4249558239 hasConcept C141071460 @default.
- W4249558239 hasConcept C2776341189 @default.
- W4249558239 hasConcept C2777546739 @default.
- W4249558239 hasConcept C2778424827 @default.
- W4249558239 hasConcept C2779384505 @default.
- W4249558239 hasConcept C2779742542 @default.
- W4249558239 hasConcept C2780596822 @default.
- W4249558239 hasConcept C509974204 @default.
- W4249558239 hasConcept C71924100 @default.
- W4249558239 hasConceptScore W4249558239C121608353 @default.
- W4249558239 hasConceptScore W4249558239C126322002 @default.
- W4249558239 hasConceptScore W4249558239C126838900 @default.
- W4249558239 hasConceptScore W4249558239C141071460 @default.
- W4249558239 hasConceptScore W4249558239C2776341189 @default.
- W4249558239 hasConceptScore W4249558239C2777546739 @default.
- W4249558239 hasConceptScore W4249558239C2778424827 @default.
- W4249558239 hasConceptScore W4249558239C2779384505 @default.
- W4249558239 hasConceptScore W4249558239C2779742542 @default.
- W4249558239 hasConceptScore W4249558239C2780596822 @default.
- W4249558239 hasConceptScore W4249558239C509974204 @default.
- W4249558239 hasConceptScore W4249558239C71924100 @default.
- W4249558239 hasIssue "8" @default.
- W4249558239 hasLocation W42495582391 @default.
- W4249558239 hasOpenAccess W4249558239 @default.
- W4249558239 hasPrimaryLocation W42495582391 @default.
- W4249558239 hasRelatedWork W113810927 @default.
- W4249558239 hasRelatedWork W2014435840 @default.
- W4249558239 hasRelatedWork W2017705908 @default.
- W4249558239 hasRelatedWork W2030303826 @default.
- W4249558239 hasRelatedWork W2348809255 @default.
- W4249558239 hasRelatedWork W2366542491 @default.
- W4249558239 hasRelatedWork W2415196927 @default.
- W4249558239 hasRelatedWork W2776620475 @default.
- W4249558239 hasRelatedWork W2996956541 @default.
- W4249558239 hasRelatedWork W3089798083 @default.
- W4249558239 hasVolume "86" @default.
- W4249558239 isParatext "false" @default.
- W4249558239 isRetracted "false" @default.
- W4249558239 workType "article" @default.